50 results
6-K
EX-4.1
QNTM
Quantum BioPharma Ltd
26 Aug 24
Current report (foreign)
6:04pm
is willing to accept, an exclusive License to the Licensed IP for the producing, processing, packaging, marketing and sales of recreational products … the boards of directors of a Licensee.
“Business” means the business of producing, processing, packaging, marketing and sales of recreational products
6-K/A
EX-99.2
QNTM
Quantum BioPharma Ltd
19 Aug 24
Condensed consolidated interim financial statements
5:18pm
, including Commercial Formulation Consultation, Contract Packaging Solutions, Ingredient Procurement, Commercialization Strategies, Initial … packaging and logo for unbuzzd™ expected to launch this summer:
On May 28, 2024, the Company confirmed the submission of a clinical trial protocol
6-K
EX-99.2
QNTM
Quantum BioPharma Ltd
14 Aug 24
Condensed consolidated interim financial statements
6:13am
, including Commercial Formulation Consultation, Contract Packaging Solutions, Ingredient Procurement, Commercialization Strategies, Initial … packaging and logo for unbuzzd™ expected to launch this summer:
On May 28, 2024, the Company confirmed the submission of a clinical trial protocol
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
16 May 24
Current report (foreign)
8:01am
EXHIBIT 99.1
FSD Pharma Provides Update on Celly Nu’s New Packaging for unbuzzd(TM)
TORONTO, ON / ACCESSWIRE / May 16, 2024 / FSD Pharma Inc … packaging and logo of unbuzzd™ expected to launch this summer, an innovative beverage product that is scientifically formulated from a proprietary blend
6-K
EX-99.2
QNTM
Quantum BioPharma Ltd
15 May 24
Condensed consolidated interim financial statements
6:02am
. This partnership will assist with the production and distribution process of unbuzzd™, including Commercial Formulation Consultation, Contract Packaging
6-K
EX-99.1
t320510w3v
25 Apr 24
Current report (foreign)
7:49am
6-K
EX-99.1
qaze2fd
22 Apr 24
Current report (foreign)
8:01am
6-K
EX-10.1
6lda0uqgs903e9xys
20 Feb 24
FSD Pharma Announces US ATM Offering
6:01am
424B5
2po0x 34d3m
16 Feb 24
Prospectus supplement for primary offering
6:36pm
F-3
eq3k cz4jorb
22 Dec 23
Shelf registration (foreign)
6:49pm
6-K
EX-99.1
mz7hqcr20w6 n7
25 Aug 23
FSD Pharma Signs Definitive Agreement to Launch UNBUZZD, a
4:18pm
6-K
EX-99.1
4tub qytl
23 May 22
Annual General Meeting of the Shareholders
4:29pm
20-F
txxgp8j5xxt8bbi6 02
31 Mar 22
Annual report (foreign)
8:09am
20-F
EX-4.2
8yqyqju6s orcfq
31 Mar 22
Annual report (foreign)
8:09am
20-F
EX-15.1
207b0pxut4 i1ds
31 Mar 22
Annual report (foreign)
8:09am
6-K
EX-99.1
pj118k4w226jivk90
12 Nov 21
Management's Discussion and Analysis of Financial Condition and Results of
9:48pm